History and Purpose

When IFFGD began, in 1991, there was little communication between patients living with functional gastrointestinal (GI) disorders and the companies with the means to develop medical or pharmaceutical products and services. Subsequently, IFFGD has worked hard to make the needs of our members known—not only to the clinicians who see patients, but also to the researchers and providers of diagnostic and treatment methods and tools.

In 1998, in an effort to strengthen our voice, we formed the IFFGD Industry Council. This helps us facilitate communication between IFFGD and the Council participants and ensure that the voice of our membership is heard. The purpose of the Industry Council is to help fulfill the mission of IFFGD—to inform, assist, and support people affected by gastrointestinal disorders.

We invite participation from companies with a demonstrated interest in these disorders. While we are grateful to our Industry Council supporters, we do not endorse any specific product or company.

Inquiries

Inquiries regarding participation in the IFFGD Industry Council should be directed to:

Nancy J. Norton, President
IFFGD
PO Box 170864
Milwaukee, WI 53217

Phone: (414) 964-1799
Fax: (414) 964-7176
About IFFGD
Leadership
Nancy J. Norton, IFFGD President
Advisory Board
Board of Directors
Editorial Board Members
Our Mission
Awareness Activities & Accomplishments
Public Education & Awareness
Professional Education & Awareness
Year in Review
-2014
-2012/2013
Advocacy Activities
Legislative Successes
FGIMD Act (Functional Gastrointestinal and Motility Disorders Research Enhancement Act)
Congressional Testimony
FISCAL YEAR 2016
FISCAL YEAR 2013
FISCAL YEAR 2012
FISCAL YEAR 2010
FISCAL YEAR 2009
FISCAL YEAR 2008
FISCAL YEAR 2007
FISCAL YEAR 2006
FISCAL YEAR 2005
FISCAL YEAR 2004
FISCAL YEAR 2003
FDA and Other Testimony
Written Comments to FDA June 29, 2015
Oral Comments to FDA May 11, 2015
Comments to FDA July 16th, 2014
Written Comments to Noridian October 24, 2013
Testimony to FDA October 25, 2012
Testimony to FDA September 12, 2012
Testimony to FDA December 13, 2011
Testimony to FDA December 2, 2010
Testimony to FDA April 23, 2002
Comments to FDA November 9, 2000
Testimony to FDA June 27, 2000
Testimony to FDA June 26, 2000
Capital Hill Advocacy Day
Research
IFFGD Research Awards
IFFGD Symposium reports
2013 Professional Symposium
10th Symposium Report
10th Symposium Audio Recordings
More from the 10th Symposium on FGIDs
2011 Professional Symposium
9th Symposium Report
2009 Professional Symposium
2007 Professional Symposium
7th Symposium Report
2005 Professional Symposium
6th Symposium Report
2003 Professional Symposium
5th Symposium Report
2002 Conference - Advancing the Treatment of Incontinence
Funding
Corporate Support
Our Research Funding Needs
IFFGD Standards for Collaboration
Industry Council
Supporters
Code of Ethics
Contact Us
Media Contact
Donation

Our Mission

healthy family

Education and Research

Our mission is to inform, assist and support people affected by gastrointestinal (GI) disorders.

IFFGD works with patients, families, physicians, health care professionals, and others to broaden understanding about gastrointestinal disorders and support or encourage research.

Awareness Activities & Accomplishments

Advocacy Activities

IFFGD Research Award